Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin).
D003877:Dermatitis, Contact / Q000209:etiology*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009824:Ointments; D010113:Oxyphenbutazone / Q000009:adverse effects*; D010653:Phenylbutazone / Q000009:adverse effects*
D009824:Ointments; D010653:Phenylbutazone; D010113:Oxyphenbutazone